Skip to main content
Erschienen in: Strahlentherapie und Onkologie 12/2018

04.09.2018 | Review Article

Health services research in German radiation oncology: new opportunities to advance cancer care

verfasst von: Daniel Medenwald, Christian T. Dietzel, Dirk Vordermark

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Health services research (HSR) is of increasing relevance to scientists, health-care providers, and clinicians. Complex population-based secondary data are a key source of information for analyses of health-care effects in radiation oncology.

Methods

In this short paper, we examine potential applications of secondary data focusing on statistics from the diagnosis-related groups (DRG). This data set incorporating all hospitalized cases in Germany is based on claims of reimbursements and is provided by the Research Data Centers (RDC) of the Federal Statistical Office and the Statistical Offices of the federal states. A short outlook regarding other data sources is also presented.

Results

In radiation oncology, secondary data such as the DRG statistics have rarely been used to examine health-care effects, despite their great potential for reporting effects in a broad population-based setting. Furthermore, for most data sources, the application to use these data is accessible with minor effort. However, data concerning outpatient care are difficult to analyze on a comparable level.

Conclusion

DRG statistics and related secondary data provide a remarkable source of information for analyses of health-care-related effects in radiation oncology.
Literatur
1.
Zurück zum Zitat Kaatsch P (2015) Krebs in Deutschland 2011/12. Robert Koch-Institut und Gesellschaft der epidemiologischenKrebsregister in Deutschland e. V., Berlin Kaatsch P (2015) Krebs in Deutschland 2011/12. Robert Koch-Institut und Gesellschaft der epidemiologischenKrebsregister in Deutschland e. V., Berlin
2.
Zurück zum Zitat Delaney G, Jacob S, Featherstone C, Barton M (2005) The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 104:1129–1137CrossRef Delaney G, Jacob S, Featherstone C, Barton M (2005) The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 104:1129–1137CrossRef
3.
Zurück zum Zitat Lievens Y, Grau C (2012) Health economics in radiation oncology: introducing the ESTRO HERO project. Radiother Oncol 103:109–112CrossRef Lievens Y, Grau C (2012) Health economics in radiation oncology: introducing the ESTRO HERO project. Radiother Oncol 103:109–112CrossRef
4.
Zurück zum Zitat Borras JM, Lievens Y, Barton M et al (2016) How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis. Radiother Oncol 119:5–11CrossRef Borras JM, Lievens Y, Barton M et al (2016) How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis. Radiother Oncol 119:5–11CrossRef
5.
Zurück zum Zitat Lievens Y, Defourny N, Coffey M et al (2014) Radiotherapy staffing in the European countries: final results from the ESTRO-HERO survey. Radiother Oncol 112:178–186CrossRef Lievens Y, Defourny N, Coffey M et al (2014) Radiotherapy staffing in the European countries: final results from the ESTRO-HERO survey. Radiother Oncol 112:178–186CrossRef
6.
Zurück zum Zitat Lohr KN, Steinwachs DM (2002) Health services research: an evolving definition of the field. Health Serv Res 37:7–9PubMed Lohr KN, Steinwachs DM (2002) Health services research: an evolving definition of the field. Health Serv Res 37:7–9PubMed
8.
Zurück zum Zitat Glocker S, Loskamp N, Bamberg M, Roeder N (2006) Evaluation of flat-rate payment in radiation oncology. German experience with disease-related groups for inpatient funding in radiation oncology. Strahlenther Onkol 182:305–311CrossRef Glocker S, Loskamp N, Bamberg M, Roeder N (2006) Evaluation of flat-rate payment in radiation oncology. German experience with disease-related groups for inpatient funding in radiation oncology. Strahlenther Onkol 182:305–311CrossRef
9.
Zurück zum Zitat Wong K, Delaney GP, Barton MB (2016) Evidence-based optimal number of radiotherapy fractions for cancer: A useful tool to estimate radiotherapy demand. Radiother Oncol 119:145–149CrossRef Wong K, Delaney GP, Barton MB (2016) Evidence-based optimal number of radiotherapy fractions for cancer: A useful tool to estimate radiotherapy demand. Radiother Oncol 119:145–149CrossRef
10.
Zurück zum Zitat Schubert-Fritschle G, Combs SE, Kirchner T, Nüssler V, Engel J (2017) Use of multicenter data in a large cancer registry for evaluation of outcome and implementation of novel concepts. Front Oncol 7:234CrossRef Schubert-Fritschle G, Combs SE, Kirchner T, Nüssler V, Engel J (2017) Use of multicenter data in a large cancer registry for evaluation of outcome and implementation of novel concepts. Front Oncol 7:234CrossRef
11.
Zurück zum Zitat Schmidberger H (2017) Reimbursement of radiotherapy in Germany. Cancer Radiother 21:544–546CrossRef Schmidberger H (2017) Reimbursement of radiotherapy in Germany. Cancer Radiother 21:544–546CrossRef
12.
Zurück zum Zitat Dasch B, Kalies H, Feddersen B, Ruderer C, Hiddemann W, Bausewein C (2017) Care of cancer patients at the end of life in a German university hospital: a retrospective observational study from 2014. PLoS ONE 12:e175124CrossRef Dasch B, Kalies H, Feddersen B, Ruderer C, Hiddemann W, Bausewein C (2017) Care of cancer patients at the end of life in a German university hospital: a retrospective observational study from 2014. PLoS ONE 12:e175124CrossRef
13.
Zurück zum Zitat Reinhold T, Dornquast C, Börgermann C, Weißbach L (2016) Treatment costs of localized prostate cancer in Germany: economic results from the HAROW observational study. Urologe A 55:1573–1585CrossRef Reinhold T, Dornquast C, Börgermann C, Weißbach L (2016) Treatment costs of localized prostate cancer in Germany: economic results from the HAROW observational study. Urologe A 55:1573–1585CrossRef
14.
Zurück zum Zitat Bekelman JE, Halpern SD, Blankart CR et al (2016) Comparison of site of death, health care utilization, and hospital expenditures for patients dying with cancer in 7 developed countries. JAMA 315:272–283CrossRef Bekelman JE, Halpern SD, Blankart CR et al (2016) Comparison of site of death, health care utilization, and hospital expenditures for patients dying with cancer in 7 developed countries. JAMA 315:272–283CrossRef
15.
Zurück zum Zitat Berger B, Ankele H, Bamberg M, Zips D (2014) Patients who die during palliative radiotherapy. Status survey. Strahlenther Onkol 190:217–220CrossRef Berger B, Ankele H, Bamberg M, Zips D (2014) Patients who die during palliative radiotherapy. Status survey. Strahlenther Onkol 190:217–220CrossRef
16.
Zurück zum Zitat Frenzel T, Krull A (2015) The use of IMRT in Germany. Strahlenther Onkol 191:821–826CrossRef Frenzel T, Krull A (2015) The use of IMRT in Germany. Strahlenther Onkol 191:821–826CrossRef
17.
Zurück zum Zitat Marnitz S, Köhler C, Rauer A et al (2014) Patterns of care in patients with cervical cancer 2012: results of a survey among German radiotherapy departments and out-patient health care centers. Strahlenther Onkol 190:34–40CrossRef Marnitz S, Köhler C, Rauer A et al (2014) Patterns of care in patients with cervical cancer 2012: results of a survey among German radiotherapy departments and out-patient health care centers. Strahlenther Onkol 190:34–40CrossRef
18.
Zurück zum Zitat Datta NR, Khan S, Marder D, Zwahlen D, Bodis S (2020) Radiotherapy infrastructure and human resources in Switzerland : present status and projected computations for. Strahlenther Onkol 2016(192):599–608 Datta NR, Khan S, Marder D, Zwahlen D, Bodis S (2020) Radiotherapy infrastructure and human resources in Switzerland : present status and projected computations for. Strahlenther Onkol 2016(192):599–608
19.
Zurück zum Zitat Zurl B, Bayerl A, De Vries A et al (2018) ÖGRO survey on radiotherapy capacity in Austria: status quo and estimation of future demands. Strahlenther Onkol 194:284–292CrossRef Zurl B, Bayerl A, De Vries A et al (2018) ÖGRO survey on radiotherapy capacity in Austria: status quo and estimation of future demands. Strahlenther Onkol 194:284–292CrossRef
Metadaten
Titel
Health services research in German radiation oncology: new opportunities to advance cancer care
verfasst von
Daniel Medenwald
Christian T. Dietzel
Dirk Vordermark
Publikationsdatum
04.09.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 12/2018
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-018-1357-4

Weitere Artikel der Ausgabe 12/2018

Strahlentherapie und Onkologie 12/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.